All problems

For UK HealthTech & MedTech companies

Your pipeline has dried up and you don't know where the next client is coming from

Early-stage companies often grow through network and founder relationships. When that pipeline runs dry, there's no systematic replacement, because the commercial infrastructure was never built. Every week without a new client conversation is revenue compounding in the wrong direction.

Cost of Inaction

Enter your top-performer and average win rates, average deal size, and number of underperforming reps. The calculator shows the annual revenue lost to a stalled commercial motion.

Estimated Annual Cost
£1,650,000
Range: £1,155,000£2,145,000
42 %
20 %
£30,000
5

How it breaks down

  • Revenue lost to the win-rate gap£1,650,000
£990,000
Realistic uplift with structured coaching

Two minutes, no typing, and I read every one myself.

Paul, Solvable

From Paul

Tell me where that £1,650,000 is coming from, and I'll come back with the three things to fix first.

A few quick questions, about two minutes, and no typing. I read every one myself and reply with the three things costing you most and where I'd start. If it's useful, we talk. If not, you've still got a clear picture.

No obligation, no sales call unless you ask for one, and nothing automated lands in your inbox.

Paul, Solvable

I reply personally, usually the same day.
  • Last three clients came from personal introductions
  • No outbound email or LinkedIn sequence running
  • Sales conversations happen reactively not proactively
  • Founder is the only person who can close a deal
  • revenue gap widens every month without new contracts
  • team capacity planning becomes impossible without pipeline visibility
  • Strategic: growth trajectory misses investor expectations

Frequently asked questions

Why does this problem persist?

Founder-led sales rarely gets systematised before it needs to be. The first ten clients come from the network. When that source runs out, there's no defined outbound motion, no lead generation channel, and no pipeline stage structure to diagnose where things are breaking. The company is commercially stuck.

This is exactly what I do with UK private practices. Answer the few questions above and I'll come back personally with where to start. Paul.

Related problems

Solvable.Health© 2026

This information is for educational purposes only and does not constitute professional advice.